Si L - Search Results

1

Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition).

Guo J, Qin S, Liang J, Lin T, Si L, Chen X, Chi Z, Cui C, Du N, Fan Y, Gu K, Li F, Li J, Li Y, Liang H, Liu J, Lu M, Lu A, Nan K, Niu X, Pan H, Ren G, Ren X, Shu Y, Song X, Tao M, Wang B, Wei W, Wu D, Wu L, Wu A, Xu X, Zhang J, Zhang X, Zhang Y, Zhu H; written on behalf of Chinese Society of Clinical Oncology (CSCO) Melanoma Panel. Guo J, et al. Among authors: si l. Chin Clin Oncol. 2016 Aug;5(4):57. doi: 10.21037/cco.2015.12.02. Epub 2015 Dec 17. Chin Clin Oncol. 2016. PMID: 27164849 Free article. No abstract available.

2

The effect of blockage of macrophage on tumor-suppressive activity of polyactin B.

Xu C, Wang X, Wang B, Han S, Zhang Y, Si L. Xu C, et al. Among authors: si l. Chin Med J (Engl). 1998 Sep;111(9):861-3. Chin Med J (Engl). 1998. PMID: 11155684

3

[An in situ study on immunostimulatory molecules in cancer cells within the cervical carcinoma tissues].

Guo J, Si L, Wang Y. Guo J, et al. Among authors: si l. Zhonghua Yi Xue Za Zhi. 2000 May;80(5):342-5. Zhonghua Yi Xue Za Zhi. 2000. PMID: 11798783 Chinese.

4

[Hepatic intra-arterial bio-chemotherapy for the treatment of melanoma patients with liver metastasis: a phase II clinical study].

Cui CL, Chi ZH, Yuan XQ, Lian HY, Si L, Guo J. Cui CL, et al. Among authors: si l. Ai Zheng. 2008 Aug;27(8):845-50. Ai Zheng. 2008. PMID: 18710619 Free article. Clinical Trial. Chinese.

5

Large-scale analysis of KIT aberrations in Chinese patients with melanoma.

Kong Y, Si L, Zhu Y, Xu X, Corless CL, Flaherty KT, Li L, Li H, Sheng X, Cui C, Chi Z, Li S, Han M, Mao L, Lu A, Guo J. Kong Y, et al. Among authors: si l. Clin Cancer Res. 2011 Apr 1;17(7):1684-91. doi: 10.1158/1078-0432.CCR-10-2346. Epub 2011 Feb 15. Clin Cancer Res. 2011. PMID: 21325067

6

Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases.

Chi Z, Li S, Sheng X, Si L, Cui C, Han M, Guo J. Chi Z, et al. Among authors: si l. BMC Cancer. 2011 Feb 25;11:85. doi: 10.1186/1471-2407-11-85. BMC Cancer. 2011. PMID: 21349197 Free PMC article.

7

A randomised phase II trial of 1 month versus 1 year of adjuvant high-dose interferon α-2b in high-risk acral melanoma patients.

Mao L, Si L, Chi Z, Cui C, Sheng X, Li S, Tang B, Guo J. Mao L, et al. Among authors: si l. Eur J Cancer. 2011 Jul;47(10):1498-503. doi: 10.1016/j.ejca.2011.03.019. Epub 2011 Apr 13. Eur J Cancer. 2011. PMID: 21493058 Clinical Trial.

8

Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification.

Guo J, Si L, Kong Y, Flaherty KT, Xu X, Zhu Y, Corless CL, Li L, Li H, Sheng X, Cui C, Chi Z, Li S, Han M, Mao L, Lin X, Du N, Zhang X, Li J, Wang B, Qin S. Guo J, et al. Among authors: si l. J Clin Oncol. 2011 Jul 20;29(21):2904-9. doi: 10.1200/JCO.2010.33.9275. Epub 2011 Jun 20. J Clin Oncol. 2011. PMID: 21690468 Clinical Trial.

9

Prevalence of BRAF V600E mutation in Chinese melanoma patients: large scale analysis of BRAF and NRAS mutations in a 432-case cohort.

Si L, Kong Y, Xu X, Flaherty KT, Sheng X, Cui C, Chi Z, Li S, Mao L, Guo J. Si L, et al. Eur J Cancer. 2012 Jan;48(1):94-100. doi: 10.1016/j.ejca.2011.06.056. Epub 2011 Jul 23. Eur J Cancer. 2012. PMID: 21788131

10

Major response to everolimus in melanoma with acquired imatinib resistance.

Si L, Xu X, Kong Y, Flaherty KT, Chi Z, Cui C, Sheng X, Li S, Dai J, Yu W, Guo J. Si L, et al. J Clin Oncol. 2012 Feb 1;30(4):e37-40. doi: 10.1200/JCO.2011.37.9644. Epub 2011 Dec 12. J Clin Oncol. 2012. PMID: 22162580 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,209 results

Search Page

Filters